The HeartQol questionnaire. Reliability, validity and responsiveness?

Similar documents
European Association for Cardiovascular Prevention & Rehabilitation (EACPR) A Registered Branch of the ESC

Supplementary Appendix

Engagement in language assessment / Regions of Europe

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

Smokefree Policies in Europe: Are we there yet?

Design and Analysis of a Cancer Prevention Trial: Plans and Results. Matthew Somerville 09 November 2009

WCPT COUNTRY PROFILE December 2017 SERBIA

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

Real Life, Real PD Survey

Adaptation and evaluation of early intervention for older people in Iranian.

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Type 1 Diabetes Australian Research Impact Analysis

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Professional International Study Management

MENTAL HEALTH CARE. OECD HCQI Expert meeting 17 th of May, Rie Fujisawa

The health economic landscape of cancer in Europe

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

OPTN/UNOS-Thoracic Organ Transplantation Committee: Proposed Modifications to Adult Heart Allocation

LEBANON. WCPT COUNTRY PROFILE December 2018

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

PROGRESS ON HCQI RESEARCH AND DEVELOPMENT WORK

DENMARK. WCPT COUNTRY PROFILE December 2018

The OECD Health Care Quality Indicators Project

Where we stand in EFORT

Models of preventive care in clinical practice to achieve 25 by 25

Q1 What age are you?

GERMANY. WCPT COUNTRY PROFILE December 2018

Overview of drug-induced deaths in Europe - What does the data tell us?

Perspectives for information on alcohol use in the EU

Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA)

Access to treatment and disease burden

BACKGROUND AND RATIONALE

Psychosocial issues and Type D personality: Effects on rehabilitation Susanne S. Pedersen (PhD), Tilburg University, The Netherlands

Primary Palliative Care Task Force. Update 3,Montreal, Oct Taskforce Members. Scott Murray, Scotland Eric van Rijswijk, Holland

European Community Pharmacy: a reference in Public Health

Allied Health: Sustainable Integrated Health Care for all Australians

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

Europa Donna in Europe and in Slovenia

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors

Appendix F. The Test-Curriculum Matching Analysis Science TIMSS 2011 INTERNATIONAL RESULTS IN SCIENCE APPENDIX F 479

Current levels and recent trends in health inequalities in the EU: Updates from the EU Report

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

Joint Programming in Neurodegenerative Disease Research (JPND)

HPV, Cancer and the Vaccination Programme

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Angelos Hatzakis. 10th Paris Hepatology Conference

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

Development of Palliative Care services in different countries

Palliative nursing care of children and young people across Europe

Rheumatoid Arthritis Disease Burden and Access to Treatment

Deceased donation data in the UK. Paul Murphy National Clinical Lead for Organ Donation United Kingdom

Immunohematology. IH-QC Modular System. Select. Combine. Control.

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

ESS Workshop, The Hague, March

Prof. Renata Cífková, MD, CSc.

Saudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière

BioPlex 2200 Infectious Disease Panels

The influence of societal individualism on a century of tobacco use: modelling the prevalence of smoking Appendices A and B

Urgent Medical Device Correction

DECLARATION OF CONFLICT OF INTEREST. None

Appendix F: Test-Curriculum Matching Analysis

Johns Hopkins individualized Health Initiative

Cross Border Genetic Testing for Rare Diseases

CARDIOVASCULAR DISEASE AND DIABETES:

Brunswik-Symmetry: A key concept for successful assessment tin education and elsewhere. Werner W. Wittmann University of Mannheim, Germany

Where do EU Contries set the limit for low risk drinking.

Overall survival: 1 st line therapy

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

Disclosure. Financial disclosure: National Advisory Board & Research Grant from Boehringer-Ingelheim

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Biology Report. Is there a relationship between Countries' Human Development Index (HDI) level and the incidence of tuberculosis?

The Identification of Food Safety Priorities using the Delphi Technique

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

Table 7.1 Summary information for lung cancer in Ireland,

Results you can trust

EASY-Care program in Iran. Dr Reza Fadayevatan, MD, MPH, PhD Head of Ageing Department, The University of Social welfare and Rehabilitation Sciences

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

THE ENTREPRENEURIAL PROPENSITY OF WOMEN

Differences make a Difference

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG-SAFE)

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

Transcription:

The HeartQol questionnaire. Reliability, validity and responsiveness? Stefan Höfer, PhD, MSc Associate Professor Medical University Innsbruck

The HeartQoL Story Data collection: 2000 2010 Presentations: 2006 (EuroPrevent Athens) : : : : 22 Minutes 2012 (EuroPrevent Dublin)

Global HRQL Physical HRQL Emotional HRQL Range: 0 (low) 3 (high)

Reliable, valid, responsive Reliable: yes/don t know Valid: yes Responsive: yes

HeartQoL Project: International 21 countries 15 languages n= 6,384 Australia; Canada; USA SE: Portugal, Spain UK, Ireland NE: Denmark, Norway, Sweden WE: Austria, Belgium, France, Netherlands, Germany, Switzerland SE: Italy EE: Hungary, Poland, Russia, Ukraine

Sample mi primary: 37.3% angina primary: 33.1% heart failure primary: 29.6% Age: 62.5±11.3 mi primary: 59.7±11.7*** angina primary: 63.1±10.2*** heart failure primary: 65.1±11.5 ***

HeartQoL patient profiles: International cohort summary HeartQoL Age / % male 62.3 / 75% BMI 27.4 Smoking 15.1% Diabetes 20.6% Treated for 90.1% Hypertension 55.4% Treated for 95.9% Hypercholesterolemia 59.6% Treated for 92.1% EuroAspire III 61.9 / 73% 28.0 18% 28% 35% 61% 89% 46% 88%

Criteria of HRQoL Instruments Conceptual and measurement model Reliability Validity Responsiveness Interpretability Alternative forms Respondent and administrative burden Objectivity Cultural and language adaptations Scientific Advisory Board, Quality of life Resaerch, 2002

Conceptual & measurement model MacNew MI Q 27 items 3 sub-scales: Physical Social Emotional Sub-scale scores Total Score Seattle Angina Q 19 items 5 sub-scales Physical limitation Angina stability Angina frequency Treatment satisfaction Disease perception Sub-scale scores Minnesota Living with Heart Failure Q 21 items 2 sub-scales Physical Emotional Sub-scale scores Total score

Conceptual & measurement model MacNew MI Q 27 items 3 sub-scales: Physical Social Emotional Sub-scale scores Total Score Seattle Angina Q 19 items 5 sub-scales Physical limitation Angina stability Angina frequency Treatment satisfaction Disease perception Sub-scale scores Minnesota Living with Heart Failure Q 21 items 2 sub-scales Physical Emotional Sub-scale scores Total score 49 items

What we did Item reduction from 49 item to as few as possible: Clinical impact method Mokken scaling Item response theory Pre-testing the prototype instrument Decision about scoring method Determination of reliability Validation Finally: 14 items

Reliability Is an instrument free from random error? Internal consistency the precision of a scale: i.e.: Cronbach s alpha Reproducibility stability over time: i.e.: Test-retest reliability

Reliability Cronbach s a Total group Angina MI Heart Failure Global score 0.91 0.90 0.90 0.91 Physical score 0.90 0.89 0.90 0.90 Emotional score 0.81 0.80 0.81 0.82 Cronbach s a: Group comparison: >0.70 Individual comparison: >0.90

Reliability compared (i.e.) Cronbach s a Total group Angina MI Heart Failure Global score 0.91 0.90 0.90 0.91 Physical score 0.90 0.89 0.90 0.90 Emotional score 0.81 0.80 0.81 0.82 Angina HeartQoL - physical.89 SF-36 - PCS SAQ physical limitations MacNew physical HRQL.93.94.95

Validity Does an instrument measure what it purports to measure? Content-related: Evidence that the domain of an instrument is appropriate relative to its intended use Construct-related: Evidence that supports a proposed interpretation of scores based on theoretical implications associated with the constructs being measured Criterion-related: Evidence that shows the extent to which scores of the instrument are related to a criterion measure

Convergent Validity SF-36 PCS SF-36 MCS p-value H-physical ++ - <.001 H-emotional - ++ <.001 p-value <.001 <.001

Convergent Validity SF-36 PCS SF-36 MCS p-value H-physical 0.68** 0.36** <.001 H-emotional 0.28** 0.60** <.001 p-value <.001 <.001 Same pattern for each diagnosis Same pattern in each country

Discriminative Validity 3 2,5 2,4 2,3 2,5 2 1,8 1,9 1,9 1,5 1 non-depressed depressed 0,5 0 Angina MI Heart Failure Same pattern for each diagnosis Same pattern in each country

Discriminative Validity 3 2,5 2 2,3 2,1 2,2 1,9 1,5 1 CCS/NYHA II CCS/NYHA III/IV 0,5 0 Angina Same pattern for each diagnosis Same pattern in each country Heart Failure

Responsiveness Is an instrument able to detect change over time? Evidence on the changes in scores of the instrument Longitudinal data that compare a group that is expected to change with a group that is expected to remain stable

PCI: N=398 CR: N=383 3 Responsiveness 2,5 ** 2,4 2 2 ** 2 1,5 1 1,7 PC Rehab 0,5 0 Baseline Follow-up

Responsiveness 0,7 Effektsize statistics SRM 0,6 0,5 0,4 0,3 0,2 Medium SF-36 HeartQoL Small 0,1 0 PCI Rehab PCI Rehab Physical Scales Emotional Scales

Criteria of HRQoL Instruments Conceptual and measurement model Reliability Validity Responsiveness Interpretability Alternative forms Respondent and administrative burden Objectivity Cultural and language adaptations Scientific Advisory Board, Quality of life Resaerch, 2002

Interpretability Are the numbers produced easily understood? Meaningful benchmarks to facilitate interpretation of the scores ( norms )... Pre post change... Clinical important difference What does a change of 0.3 on the HeartQoL actually mean?

Summary: HeartQoL Reliable: yes/don t know Valid: yes Responsive: yes

HeartQoL - Future To check for: test-stability interpretability Comparing with current gold standard(s) i.e. MacNew Health-related quality of life instrument Application